Northrop Grumman’s Record Backlog Meets a Skeptical Market

Third-quarter earnings beat forecasts and guidance rose again, but a lower tax rate, one-off cash and the F/A-XX loss leave investors asking how durable Northrop’s momentum really is.

Key Takeaways

• Sales rose 7% to $11.1 billion and diluted EPS reached $7.89 against a $7.18 consensus, with Aeronautics and Defense Systems growing at double-digit rates on F-35, B-21 and Sentinel work.
• Net awards of $16.4 billion lifted backlog to a record $109.6 billion, up 15% this year, though less than half is funded, tying future growth to the pace of Washington’s appropriations.
• Northrop raised 2026 MTM-adjusted EPS guidance by $0.70 to as much as $29.75 while holding sales and cash targets, a signal that execution, not volume, is now driving the upgrades.

The Shape of the Beat

Northrop Grumman entered its third-quarter report with expectations set low enough to be cleared without drama. Analysts had forecast earnings of $7.18 a share, below the $7.67 reported a year earlier, on revenue of roughly $11.12 billion. The company delivered $7.89 on sales of $11.1 billion, up 7% from $10.4 billion, with all four sectors contributing growth. Net earnings rose 2% to $1.12 billion. It was the fifth consecutive quarter in which Northrop beat the consensus estimate, and the second in a row in which it raised its full-year profit guidance.

On their own, those figures describe a company in good order. The more useful question for investors is what kind of beat this was. A defense prime’s earnings can rise for reasons that say a great deal about its future, such as better execution on fixed-price production or a favorable shift in contract mix. They can also rise for reasons that say very little, such as a lower tax bill or a change in pension accounting. Northrop’s third quarter contained both kinds. Separating them explains why the stock has struggled to respond to a run of results that, on paper, look consistently strong.

Where the Earnings Came From

Start with the operating line. Total operating income rose only 2% to $1.27 billion, and the reported operating margin narrowed to 11.4% from 11.9%. The main drag was the FAS/CAS pension adjustment, the accounting bridge between pension expense under financial reporting rules and the pension costs Northrop recovers through government contracts. That adjustment contributed $52 million less than a year earlier, an effect with no bearing on how well the company builds aircraft or missiles. Segment operating income, which strips out such items and better reflects the businesses themselves, rose 5% to $1.35 billion, at a segment margin of 12.1% against 12.3% a year ago.

Below the operating line, two items did much of the work. The non-operating pension benefit rose to $167 million from $136 million, and the effective tax rate fell to 13.4% from 16.9% on higher research credits. Applying last year’s tax rate to this year’s pretax earnings of $1.30 billion would have produced EPS of roughly $7.57. That would still have beaten consensus comfortably, so the tax benefit did not manufacture the result. It did account for close to half of the upside, however, and investors tracking Northrop’s earnings quality will have noticed. Analysts made a similar observation in July, when they attributed much of the second-quarter beat to a lower tax rate.

Aeronautics and the Bomber’s Economics

The operational story is strongest in Aeronautics Systems, where sales grew 14% to $3.58 billion. The F-35 added $195 million on the timing of material costs and higher sustainment volume. B-21 Raider sales increased, and B-2 sustainment work expanded. Operating income rose 24% to $377 million, and the sector margin improved to 10.5% from 9.7%, helped by favorable contract adjustments on mature production and sustainment programs.

The nine-month comparison requires care. Aeronautics operating income has risen 136% this year to $1.04 billion, but the 2025 base included a $477 million B-21 loss provision. Much of the improvement therefore reflects the absence of that charge rather than a transformation in profitability. The more meaningful signal is forward-looking: management raised its full-year Aeronautics margin guidance to the high 9% range, from mid to high 9%. On a business of roughly $14 billion in annual sales, the change is modest. Its significance lies in what it implies about the bomber, the program on which the sector’s long-term value most depends. Management has said that accelerating B-21 production would require $2 billion to $3 billion of investment over several years, with the benefit most visible from 2027 through 2029.

Defense Systems and the Munitions Pipeline

Defense Systems grew sales 12% to $2.31 billion, its fastest rate of the year. Sentinel, the program to replace the Minuteman III intercontinental ballistic missile, added $180 million as it ramps. Volume also increased on the extended-range Guided Multiple Launch Rocket System and on tactical solid rocket motors, partly offset by lower output on certain ammunition programs. Operating income rose 7% to $250 million, while the margin eased to 10.8% from 11.4% as the mix moved toward cost-type contracts. Those contracts carry less risk for the contractor and correspondingly lower returns.

In context, that is an acceptable exchange. In the second quarter, higher development costs on the Stand-in Attack Weapon cut the sector’s operating income by 38%, an episode that sharpened investor concern about fixed-price development risk. A quarter of volume-led growth without new charges does not close that chapter, but it returns attention to demand, which is plainly strong. In July, Northrop said it had qualified as a supplier on the PAC-3 interceptor under a $2 billion framework with the Pentagon and Lockheed Martin. It also said its multiyear missile agreements represent up to $10 billion of sales over seven years. The company expects tactical solid rocket motor output at its West Virginia facility to reach roughly three times its 2021 level by early 2027. Few assets in the defense industrial base are as constrained, or as strategically valuable, as rocket motor capacity.

Mission and Space: Steady and Largely Classified

Mission Systems and Space Systems each grew 2%, and both deserve more attention than those growth rates suggest. Mission Systems remains Northrop’s highest-margin business, earning 15.8% on $3.16 billion of sales, supported by restricted airborne radar and marine systems programs. The margin fell from 16.7%, but the prior-year figure included a $68 million favorable estimate revision in restricted microelectronics. Management also raised the sector’s full-year margin guidance to the mid-15% range from about 15%. The decline is a matter of comparison, not performance.

Space Systems absorbed $136 million of lower Commercial Resupply Services revenue, the result of launch timing, and still grew on the strength of its restricted portfolio. Its margin improved to 11.3% from 11.0% as fixed-price content rose. Classified work runs through the entire quarter: of $16.4 billion in net awards, $4.6 billion came from restricted programs, primarily in Aeronautics, Space and Mission Systems. For investors, this is an uncomfortable form of exposure, since the programs cannot be analyzed in any detail. It is also among the most durable revenue in the defense budget, concentrated in capabilities that are rarely sacrificed when funding tightens.

A Record Backlog, With Conditions

The quarter’s most consequential number was its order intake. Net awards included $2.0 billion for Sentinel, $1.4 billion for Virginia-class submarine work, $1.3 billion for the F-35 and $1.0 billion for the E-2 airborne early warning aircraft. The book-to-bill ratio was roughly 1.5 times, and total backlog reached a record $109.6 billion. That is up from $104.7 billion at the end of June and 15% higher than at the start of the year. Defense Systems backlog has grown 31% since December to $36.5 billion, the clearest evidence that spending on strategic deterrence and munitions is turning into signed contracts.

Two qualifications apply. First, funded backlog stands at $50.1 billion, so more than half of the total has yet to be appropriated by Congress. Northrop’s growth is therefore tied to the timing and reliability of the federal budget process, a dependency the company’s own risk disclosures address directly, including the possibility of a prolonged continuing resolution or government shutdown. Second, the largest contributor to backlog growth carries its own complications. Sentinel added $7.6 billion to backlog in the second quarter as the Air Force further definitized the contract. Yet the program has a history of significant cost growth, its development phase runs under a cost-type arrangement, and its production phases remain subject to revised baselines and future negotiation. Sentinel offers long-duration revenue with limited near-term margin risk. Its eventual profitability has yet to be determined.

Cash, Capital and the Buyback Pause

Cash generation improved, though the headline figure needs annotation. Operating cash flow rose 12% to $1.75 billion on better trade working capital, and adjusted free cash flow increased 44% to $1.81 billion. That total included $371 million in proceeds from the sale of equipment to a customer, which Northrop counts within its adjusted measure. Excluding it, free cash flow would have been about $1.44 billion, still a solid result. Year to date, adjusted free cash flow stands at $965 million against an unchanged full-year target of $3.1 billion to $3.5 billion. Reaching even the low end requires more than $2.1 billion in the fourth quarter, a heavy weighting, though not an unusual one for a contractor whose collections tend to concentrate at year-end.

The more striking shift is in capital allocation. Share repurchases totaled $68 million in the first nine months of 2026, compared with $1.17 billion a year earlier. Dividends rose to $1.04 billion, and long-term debt declined to $14.4 billion from $15.2 billion at the end of 2025. The pattern is consistent with a management team directing cash toward production capacity, from rocket motors to the B-21, ahead of buybacks. That choice is defensible when demand is visible and capacity is scarce. It also changes the character of the shareholder return, at least for now, from one supported by a shrinking share count to one that depends more heavily on future earnings growth.

Guidance and the Fourth-Quarter Test

The guidance revision was narrow but well chosen. Northrop held its 2026 sales range at $43.75 billion to $44.25 billion and left its cash flow target unchanged. It raised segment operating income guidance by $65 million at the midpoint, to $4.94 billion to $5.04 billion. It lifted MTM-adjusted EPS guidance by $0.70 at the midpoint, to $29.35 to $29.75, above a consensus near $28.98. Higher profit guidance on unchanged revenue points to better execution rather than greater volume, the improvement investors have sought since margins disappointed in the first half.

The unchanged sales range implies fourth-quarter revenue of roughly $11.9 billion to $12.4 billion, which would make it the strongest quarter of the year. That fits the second-half acceleration management described in July, but it leaves the final quarter carrying real weight for both sales and cash. Chief executive Kathy Warden looked further ahead, saying the record backlog, portfolio and investments would “continue to drive sales and earnings growth as reflected in our 2027 outlook.” The language signals confidence in next year. The figures behind it will matter more than the language.

The F/A-XX Loss and the Market’s Verdict

The market has learned to treat this company’s good quarters with reserve. Northrop shares closed at $510.65 on the eve of the release, down nearly 15% over twelve months and roughly a third below their March record. In July, a quarter that beat estimates and raised guidance still sent the stock lower as investors fixed on segment margins. Sentiment weakened further on September 29, when the Pentagon selected Boeing to build the Navy’s F/A-XX sixth-generation fighter under a development contract reported at more than $20 billion. The decision leaves Northrop outside both U.S. crewed sixth-generation fighter programs. It also ends, for now, the company’s effort to return as prime contractor on a Navy fighter for the first time since the Grumman F-14.

The loss removes an option on growth beyond this decade, not a source of current revenue, and what remains is a deep portfolio: the B-21, Sentinel, an expanding munitions and propulsion business, and a classified space and sensors franchise. Analysts are divided on how to price it. Bernstein cut its price target to $556 from $620 on October 14 while keeping a Market Perform rating, and Rothschild Redburn initiated coverage a week earlier with a Buy rating and a $680 target. With the shares trading below 18 times forward earnings before the release, the valuation already reflects considerable doubt.

Another quarter like this one will not settle that doubt. What would settle it is evidence of conversion: a $110 billion backlog becoming revenue at steadily improving margins, and that revenue becoming cash that can again be returned to shareholders at scale. The third quarter moved Northrop in that direction. The fourth quarter, and the 2027 outlook that comes with it, will show how far.